EDITPEP INC

BERKELEY, CA · Founded 2022 · CIK 0002049446 · Biotech · Private

PERC platform for non-viral genome editing delivery to the brain and beyond

editpep.bio →
Grants
$305K
1 award
Sector median: 1
Raised
$8.2M
1 Form D · Dec 2024
22 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$8,200,000
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Development of Brain-penetrant Non-viral Genome-editing Therapies for Central Nervous System Disorders$304,994
Federal grant · SBIR/STTRForm D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1275NANOTHERAPEUTICS, INC.——
1276FIBROPLATE INC——
1277Purine Pharmaceuticals Inc.——
1278EDITPEP INC—$8.2M
1279DNATWO, INC.——
1280ASYMMETREX, LLC——
1281FPRT BIO, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 3 related persons
  • Dana FossDirector · Executive Officer · Promoter
  • Jaromir TesarDirector
  • Ross WilsonDirector · Executive Officer · Promoter

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.